GLP1R and diabetic kidney disease: Additionally, the level of C-peptide, which was found to inhibit tubulointerstitial fibrosis [52], was increased by GLP-1 RAs and this may be one of the ways of improving tubuluinterstitial and tubular injury in GK rats with diabetic nephropathy [51].